{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1433","meta":{"versionId":"6","lastUpdated":"2018-03-14T01:00:05.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2018-03-14"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1433","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1433"}],"version":"20180314","name":"BrompheniramineDihydrocodeinePseudoephedrine","title":"Brompheniramine / Dihydrocodeine / Pseudoephedrine","status":"active","experimental":false,"date":"2018-03-14T01:00:05-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1234968","display":"Brompheniramine Maleate 0.6 MG/ML / dihydrocodeine bitartrate 1.5 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Solution"}]}]},"expansion":{"identifier":"urn:uuid:96aa2ace-c23c-4a6c-baa2-1539bfc9983e","timestamp":"2023-12-11T02:33:04-05:00","total":0}}